Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.220
+0.120 (10.91%)
At close: Aug 13, 2025, 4:00 PM
1.150
-0.070 (-5.74%)
Pre-market: Aug 14, 2025, 9:18 AM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $89.64 million as of August 14, 2025. Its market cap has increased by 68.24% in one year.
Market Cap
89.64M
Enterprise Value
79.36M
1-Year Change
68.24%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $89.64M, a decrease of -65.05%. That is a compound annual growth rate of -23.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 89.64M | 207.63% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |